PD-1, PD-L1 Inhibitors Could Carve Out 750 Billion Yen Market in Japan: Citi Analyst

Hidemaru Yamaguchi, Managing Director, Fundamental Analysis, Citi Research, Citigroup Global Markets Japan Anti-PD-1 and PD-L1 antibodies could notch up sales to the tune of 750 billion yen in Japan for the treatment of non-small cell lung cancer alone, stirring up...read more